indacaterol

adrenoceptor beta 2 ; Homo sapiens







22 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 31425937 Ultra-LABAs for the treatment of asthma. 2019 Sep 1
2 29653961 Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of β2-Adrenoceptor Agonists. 2018 Jul 3
3 28284212 Combination of glycopyrronium and indacaterol inhibits carbachol-induced ERK5 signal in fibrotic processes. 2017 Mar 11 1
4 27832943 Evaluation of the anti-inflammatory effects of β-adrenoceptor agonists on human lung macrophages. 2016 Dec 15 1
5 25781609 Olodaterol attenuates citric acid-induced cough in naïve and ovalbumin-sensitized and challenged guinea pigs. 2015 1
6 24733958 The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro. 2014 1
7 25134539 Indacaterol inhibits tumor cell invasiveness and MMP-9 expression by suppressing IKK/NF-κB activation. 2014 Aug 1
8 23667224 Indacaterol-induced severe constipation and abdominal pain: is there a role for colonic β3-adrenoceptors? 2013 May 9 1
9 22158330 A pharmacogenetic study of ADRB2 polymorphisms and indacaterol response in COPD patients. 2012 Dec 2
10 22356291 Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease. 2012 Mar 5 1
11 22790232 [Pharmacological and clinical profile of indacaterol maleate (Onbrez®), an inhaled long-acting β₂-adrenoceptor agonist]. 2012 Jul 1
12 22932315 An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterol. 2012 Oct 1 2
13 21184620 Efficacy, safety and pharmacokinetics of indacaterol in Caucasian and Japanese patients with chronic obstructive pulmonary disease: a comparison of data from two randomized, placebo-controlled studies. 2011 1
14 20402514 The identification of indacaterol as an ultralong-acting inhaled beta2-adrenoceptor agonist. 2010 May 13 1
15 20467588 Indacaterol for chronic obstructive pulmonary disease (COPD). 2010 Mar 2
16 20694063 Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist. 2010 Jun 15 1
17 21080743 Indacaterol: in chronic obstructive pulmonary disease. 2010 Dec 3 1
18 19422388 Pharmacogenetic characterization of indacaterol, a novel beta 2-adrenoceptor agonist. 2009 Sep 2
19 19452036 Indacaterol, A Novel Once Daily Inhaled beta2-Adrenoreceptor Agonist. 2009 Mar 12 2
20 17916760 Pharmacological characterization of indacaterol, a novel once daily inhaled 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices. 2008 Jan 1
21 17135231 Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi. 2007 Mar 2
22 16434564 In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. 2006 May 1